Welcome!

Agile Computing Authors: Liz McMillan, Elizabeth White, Pat Romanski, Xenia von Wedel, Rishi Bhargava

News Feed Item

Greenway Reports Fiscal 2013 Second-Quarter Results, Revises Outlook for Fiscal 2013

Greenway Medical Technologies, Inc. (NYSE: GWAY), which delivers innovative software and business services solutions for ambulatory care providers through its PrimeSUITE® platform, today announced financial results for the three months and six months ended December 31, 2012, as well as a revised outlook for results from operations for fiscal 2013.

“Our results for the second quarter of our fiscal year reflect continued strong growth of recurring revenue as providers adopt our cloud-based services, offset by a decline in revenue related to deployment,” said Tee Green, president and chief executive officer of Greenway®. “We added more than 750 providers to our network during the second quarter, and we are gaining appeal among larger healthcare system accounts — transactions that are more complex and take more time to complete. We believe that the update to our outlook for the remainder of fiscal 2013 reflects an appropriate adjustment to the impact of an increasing percentage of our revenue derived from recurring sources.”

Highlights

Highlights for the fiscal 2013 second quarter, when compared with the prior-year period, include:

  • Revenue growth of 12%, which includes recurring revenue growth of 32%;
  • Gross profit growth of 16% results in gross margin expansion of 177 basis points;
  • Cash flow from operations growth of 22% to $3.7 million.

Operating Results

For the three months ended December 31, 2012, Greenway generated revenue of $32.7 million, a 12% increase from $29.1 million for the comparable prior-year period. Revenue from recurring sources grew by 32%, and comprised 55% of total revenue for the fiscal 2013 second quarter. This compares with recurring revenue of 47% of total revenue for the prior-year period. The growth in recurring revenue as a percent of total revenue is a function of increased adoption of Greenway’s cloud-based services, including PrimeSUITE, PrimePATIENT® patient portal and PrimeEXCHANGE®, as well as the growth of PrimeRCM®, Greenway’s clinically driven revenue cycle management platform. Greenway’s revenue mix for the second quarter was impacted by a decline in Training and Consulting revenue related to fewer deployments than in the prior-year period. Through the first half of fiscal 2013, Greenway’s revenue has grown by 20%, to $65.5 million, compared with $54.8 million for the first half of fiscal 2012.

Greenway generated gross profit of $17.4 million for the three months ended December 31, 2012, an increase of 16% from $15.0 million for the prior-year period.

Gross profit margin for the fiscal 2013 second quarter improved by 177 basis points, to 53.2%, as a result of growth related to recurring subscription solutions and services, offset by a decline in gross margin for System Sales and Training and Consulting Services. Gross margin for recurring revenue sources grew to 57.8% for the three months ended December 31, 2012, from 49.9% for the prior-year period, as the customer adoption of innovative solutions increased and the Company improved margins on Customer Support Services and EDI and Business Services. Gross margin for System Sales and Training and Consulting Services declined as a result of fewer deployments in the quarter, compared to the prior-year period.

Greenway has earned gross profit of $35.3 million, and overall gross margin has improved to 53.8%, through the six months ended December 31, 2012. This compared with gross profit of $28.3 million, and gross margin of 51.6%, for the first half of the prior fiscal year.

Greenway reported a loss from operations of ($1.8 million) for the fiscal 2013 second quarter, which compares with an operating loss of ($350,000) for the prior-year period. Through six months ended December 31, 2012, Greenway has reported an operating loss of ($2.0 million), which compares with an operating loss of ($900,000) for the prior-year period.

The Company had a net loss of ($985,000), or (three cents) per share, based on a weighted average 30.9 million shares outstanding, for the three months ended December 31, 2012. This compares with a net loss of ($268,000) for the prior-year period. The Company’s results for the three months ended December 31, 2011, reflected income available to common shareholders of $37.8 million, or $1.70 per share based on a weighted average 22 million shares outstanding. This included dividends and accretion related to preferred stock that was converted to common stock in February 2012.

As of December 31, 2012, Greenway had $27.4 million in cash and short-term investments and no outstanding indebtedness.

Greenway generated cash flow from operations of $3.7 million for the fiscal 2013 second quarter, up from $3.0 million for the comparable prior-year period. Through the first six months of fiscal 2013, Greenway generated cash flow from operations of $6.0 million, up from $3.8 million for the comparable period of fiscal 2012.

Non-GAAP Measures

Greenway’s non-GAAP adjusted EBITDA, which is defined as earnings before interest, taxes, depreciation and amortization, acquisition-related transaction costs and stock-based compensation, was $1.3 million for the three months ended December 31, 2012, unchanged from the prior-year period, and for both periods non-GAAP EBITDA margin was 4%. Through six months ended December 31, 2012, Greenway’s adjusted EBITDA was $3.9 million, or 6% of revenue, a 75% increase from $2.2 million, or 4% of revenue, for the first half of the prior fiscal year.

Adjusted, or non-GAAP net income (loss), which is defined as net income before stock-based compensation, acquisition-related transaction costs and amortization of purchased intangibles and any estimated tax impact related to these items, was $(41,000), or (zero) cents per diluted share, for the three months ended December 31, 2012. This compares with non-GAAP net income of $231,000, or one cent per diluted share for the second quarter of fiscal 2012. For the six months ended December 31, 2012, Greenway’s non-GAAP net income was $843,000, or two cents per share, which compares with adjusted net income of $512,000 for the first half of the prior fiscal year, or two cents per share.

The GAAP financial measures most directly comparable to each non-GAAP financial measure used, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release following the condensed financial statements.

Fiscal 2013 Outlook Update

Greenway Medical Technologies is updating its previously issued outlook for Fiscal 2013, based on actual results for the first half of the fiscal year. Greenway believes that its revenue will grow by 17% to 21% for the 12 months ended June 30, 2013, from fiscal 2012 actual results, while achieving gross margin and adjusted EBITDA margin improvement. The following table summarizes the Company’s revised outlook for fiscal 2013 as of February 12, 2012:

       
   

Range

($ in millions except

     

per share data)

Revenue     $145.0 to $150.0
Gross Profit     $79.0 to $84.0
Margin     54.5% to 56.0%
Operating Income     $5.5 to $8.3
Effective Tax Rate     40%
Net income     $3.1 to $5.2
GAAP EPS     $0.10 to $0.17
Adjusted EBITDA     $18.0 to $21.0
Margin     12.4% to 14.0%
Adjusted EPS     $0.21 to $0.28
 

Conference Call

Greenway will host a conference call today, Tuesday, February 12, 2013, at 5 p.m. Eastern time to discuss the Company's earnings and other information. The call can be accessed by dialing (888) 679-8034 or (617) 213-4847 for international calls. The participant code is 98566108. For listen-only mode, participants should go to the Investors section of www.greenwaymedical.com prior to the call to register and download the necessary audio software.

An audio replay will be posted following the call and will be available from approximately 7 p.m. Eastern time on Feb. 12 through 11:59 p.m. Eastern time on Feb. 19. The replay will be accessible through a link on www.greenwaymedical.com/investors or by calling (888) 286-8010 or internationally (617) 801-6888. Replay code is 69503212.

About Greenway and PrimeSUITE

Greenway Medical Technologies, Inc. (NYSE: GWAY) delivers smarter solutions for smarter healthcare. PrimeSUITE® — Greenway’s certified and fully integrated electronic health record, practice management and interoperability solution — helps improve care coordination, quality and cost-efficiency as part of a smarter, sustainable healthcare system. Thousands of ambulatory care providers across more than 30 specialties and sub-specialties use cloud-based, remote-hosted or on-premise Greenway® solutions in healthcare enterprises, physician practices and clinics nationwide. For details, see greenwaymedical.com, Twitter, Facebook or YouTube.

Forward-Looking Statements

In addition to historical information, this press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the Company’s financial condition, growth strategy, business development efforts, service offerings, and service delivery models. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the Company’s future performance include, but are not limited to, our ability to adapt to evolving technology and industry standards; our ability to implement our growth strategy; our ability to retain management and other qualified personnel; failure to prevent disruptions in service or damage to our third-party providers’ data centers; failure to avoid liability for the use of content we provide; regulation of the healthcare information technology industry; our ability to ensure our solutions meet industry and government standards; failure to maintain adequate security measures for our customers’ confidential information and personal identifiable information and their patients’ protected health information; our ability to obtain new provider clients; failure of the HITECH Act and other incentive programs to be fully implemented or funded by the government; our ability to implement our strategic relationships as currently intended; failure to establish, protect or enforce our intellectual property; restrictions in our credit facility and future indebtedness. Further information concerning these and other factors is included in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2012. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

Greenway, the Greenway logo, PrimeSUITE, PrimePATIENT, PrimeEXCHANGE and PrimeRCM are registered trademarks and the phrase “smarter solutions for smarter healthcare” is a trademark of Greenway Medical Technologies, Inc. Other product and company names are the property of their respective owners.

 
Greenway Medical Technologies, Inc.
 
Condensed Balance Sheets – Unaudited
(In Thousands)
         
December 31, June 30,
2012 2012
Assets
Current assets:
Cash and cash equivalents $ 8,217 $ 5,585
Short-term investments 19,161 29,350
 
Accounts receivable, net of a $763 and $720 allowance for doubtful accounts at December 31, 2012 and June 30, 2012, respectively 22,634 28,875
Inventory 283 281
Prepaids and other current assets 2,387 3,001
Deferred tax assets   1,679     1,699  
Total current assets 54,361 68,791
Property and equipment, net 29,334 20,340
Software development cost, net 21,543 17,156
Acquired intangibles, net 2,092 510
Deferred tax assets - noncurrent 26,697 25,846
Goodwill 1,438 440
Other assets   467     40  
Total assets $ 135,932   $ 133,123  
 
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable $ 12,829 $ 12,436
Accrued liabilities 10,372 9,533
Deferred revenue   10,121     12,192  
Total current liabilities   33,322     34,161  
 
Obligation for purchased technology   -     116  
Shareholders’ equity:
Common stock 3 3
Additional paid-in capital 242,299 237,558
Accumulated deficit   (139,692 )   (138,715 )
Total shareholders’ equity   102,610     98,846  
Total liabilities and shareholders’ equity $ 135,932   $ 133,123  
 
 

Greenway Medical Technologies, Inc.
 
Condensed Statements of Operations – Unaudited
(In Thousands except Per Share Data)
         
Three Months Ended December 31, Six Months Ended December 31,
2012     2011 2012     2011
Revenue:
System sales $ 10,638 $ 9,205 $ 19,673 $ 15,854
Training and consulting services 4,107 6,301 10,970 12,904
Support services 11,059 7,710 21,351 14,767
Electronic data interchange and business services   6,917     5,906     13,501     11,248  
Total revenue   32,721     29,122     65,495     54,773  
Cost of revenue (Note 1):
System sales 4,415 2,761 7,422 4,608
Training and consulting services 3,312 4,560 7,914 8,992
Support services 3,189 2,672 6,314 4,929
Electronic data interchange and business services   4,399     4,153     8,593     7,975  
Total cost of revenue   15,315     14,146     30,243     26,504  
Gross profit   17,406     14,976     35,252     28,269  
Operating expenses (Note 1):
Sales, general and administrative 14,749 11,482 28,073 22,160
Research and development   4,440     3,844     9,212     7,008  
Total operating expenses   19,189     15,326     37,285     29,168  
Operating loss

 

( 1,783 ) (350 ) ( 2,033 ) (899 )
Interest income (expense), net ( 16 ) - 273 (8 )
Other expense, net   ( 17 )   (48 )   ( 41 )   (87 )
Loss before benefit for income taxes ( 1,816 ) (398 ) ( 1,801 ) (994 )
Benefit for income taxes   ( 831 )   (130 )   ( 824 )   (320 )
Net loss ( 985 ) (268 ) ( 977 ) (674 )
Preferred stock dividends and accretion   -     37,772     -     28,395  
Income (loss) available to common shareholders $ ( 985 ) $ 37,504   $ ( 977 ) $ 27,721  
Per share data:
Net income (loss) per share available to common shareholders:
Basic $ (0.03 ) $ 3.19   $ (0.03 ) $ 2.37  
Diluted $ (0.03 ) $ 1.70   $ (0.03 ) $ 1.26  
Weighted average number of common shares outstanding:
Basic   29,576     11,686     29,435     11,713  
Diluted   30,905     22,044     30,670     21,984  
 
 
Note 1 - Includes stock-based compensation in the following amounts:
Cost of revenue:
System sales $ 8 $ ( 2 ) $ 16 $ 6
Training and consulting services 48 119 95 211
Software support services 27 3 53 82
Electronic data interchange and business services   5     43     10     43  
Total cost of revenue   88     163     174     342  
Operating expenses:
Sales, general and administrative 791 343 1,634 557
Research and development   169     ( 76 )   339     588  
Total operating expenses   960     267     1,973     1,145  
Total stock-compensation expense $ 1,048   $ 430   $ 2,147   $ 1,487  
 
 

Greenway Medical Technologies, Inc.
 
Condensed Statements of Cash Flows – Unaudited
(Amounts in Thousands)
   
Six Months Ended December 31,
2012     2011
Cash flows from operating activities:
Net loss $ (977 ) $ (674 )
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net stock compensation expense 2,147 1,487
Deferred income tax benefit ( 831 ) ( 377 )
Depreciation and amortization 3,692 1,609
Provision for bad debts 951 570
Changes in current assets and liabilities:
Accounts receivable 5,359 1,432
Inventory ( 2 ) ( 273 )
Prepaids and other current assets 187 ( 945 )
Accounts payable and accrued liabilities ( 2,428 ) 497
Deferred revenue   ( 2,071 )   480  
Net cash provided by operating activities   6,027     3,806  
Cash flows from investing activities:
Sales of short-term investments - net 10,189 5,689
Purchases of property and equipment ( 5,837 ) ( 2,953 )
Acquisition of business and developed technology ( 2,875 ) ( 3,000 )
Capitalized software development cost   ( 6,420 )   ( 5,838 )
Net cash used in investing activities   (4,943 )   (6,102 )
Cash flows from financing activities:
Payments on obligation for acquired technology (46 ) ( 77 )
Proceeds from exercise of stock options and warrants, net of issuance costs 2,594 199
Contingent consideration paid for prior acquisition   (1,000 )   -  
Net cash provided by financing activities   1,548     122  
Net decrease in cash and cash equivalents 2,632 (2,174 )
Cash and cash equivalents at beginning of period   5,585     5,722  
Cash and cash equivalents at end of period $ 8,217   $ 3,548  
Supplemental cash flow information:
Cash paid for interest $ 35   $ 3  
Cash paid for taxes $ 122   $ 58  
Non-cash investing and financing activities:
Future obligation for acquisition of business and developed technology $ 3,875   $ -  
Common stock and obligations for future payments at fair value, given in exchange for acquisition of technology $ -   $ 954  
 
 

Reconciliation of Non-GAAP Financial Measures to Comparable GAAP Measures

(Unaudited, in thousands, except share amounts)

The following is a reconciliation of the non-GAAP financial measures used by the Company in describing its financial performance in accordance with U.S. “generally accepted accounting principles” (GAAP). An explanation of these measures is also included below under the heading “Explanation of Non-GAAP Financial Measures”. While management believes these non-GAAP financial measures provide useful supplemental information to investors regarding the Company’s operations, investors are reminded to consider these non-GAAP measures in addition to, and not a substitute for, financial performance measures in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the future. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company’s results of the operations as determined in accordance with GAAP.

Non-GAAP Adjusted EBITDA

(Unaudited, in thousands)

Set forth below is a presentation of the Company’s “non-GAAP Adjusted EBITDA” and the “non-GAAP Adjusted EBITDA Margin” which is non-GAAP Adjusted EBITDA as a percentage of total revenue:

  Three Months Ended December 31,     Six Months Ended December 31,
2012     2011 2012     2011
 
Reconciliation of net income (loss) to Non-GAAP Adjusted EBITDA:
Net income (loss)

$

( 985 )

$

( 268 )

$

( 977 )

$

( 674 )
Stock-based compensation 1,048 430 2,147 1,487
Acquisition-related transaction costs 131 123 131 123
Depreciation and amortization 1,908 1,149 3,692 1,609
Interest (income) expense, net 16 ( 1 ) ( 273 ) 8
Provision (benefit) for income taxes ( 831 ) ( 130 ) ( 824 ) ( 320 )
Non-GAAP adjusted EBITDA

$

1,287  

$

1,303  

$

3,896  

$

2,233  
 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Adjusted Net (Loss) Income

(Unaudited, in thousands except per share amounts)

Set forth below is a reconciliation of the Company’s “Non-GAAP Adjusted Net (Loss) Income” and “Non-GAAP Adjusted Net (Loss) Income per Diluted Share”:

    Three Months Ended December 31,     Six Months Ended December 31,
2012     2011 2012     2011
 
Non-GAAP adjusted net (loss) income
GAAP net loss

$

( 985 ) $ (268 )

$

( 977 ) $ (674 )
 
Add: Stock-based compensation 1,048 430 2,147 1,487
Add: Acquisition-related transaction costs 131 123 131 123
Add: Amortization of purchased intangibles   394     281     755     369  
Subtotal of tax deductible items   1,573     834     3,033     1,979  
Less: tax impact of tax deductible items (40% rate)   ( 629 )   (334 )   ( 1,213 )   (792 )
Non-GAAP adjusted net (loss) income

$

( 41 ) $ 231  

$

843   $ 512  
 
Weighted average number of shares - diluted 30,905 22,044 30,670 21,984
 
Non-GAAP adjusted net (loss) income per diluted share $ (0.00 ) $ 0.01 $ 0.03 $ 0.02
 
 
Three Months Ended December 31, Six Months Ended December 31,
2012 2011 2012 2011
 
Net loss per share $ (0.03 ) $ (0.01 )

 

$ (0.03 ) $ (0.03 )
 
Add: Stock-based compensation

 

0.04

 

0.02

 

0.07

 

0.06
Add: Acquisition-related transaction costs

 

-

 

-

 

-

 

-
Add: Amortization of purchased intangibles

 

0.01  

 

0.01  

 

0.02  

 

0.02  
Subtotal of tax deductible items $ 0.05   $ 0.03   $ 0.09   $ 0.08  
Less: tax impact of tax deductible items (40% rate) $ (0.02 ) $ (0.01 ) $ (0.04 ) $ (0.03 )
Non-GAAP adjusted net (loss) income per share - diluted $ (0.00 ) $ 0.01   $ 0.02   $ 0.02  
 

Explanation of Non-GAAP Measures

The Company reports its financial results in accordance with U.S. GAAP. The Company’s management believes that investors may wish to consider the impact of certain non-cash or non-recurring items as a supplement to financial performance measures in accordance with GAAP. These items result from facts and circumstances that may vary in frequency and impact on continuing operations. Management also presents results of operations before such items to evaluate operating performance, compare performance against past periods and as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate operating results and trends by eliminating certain non-cash expenses and other items that management believes might complicate comparisons with prior periods, obscure current trends or reduce the ability to make useful forecasts. Management believes that these non-GAAP measures provide additional means of evaluating performance, period-over-period. In addition, management understands that some investors and financial analysts find this information useful in analyzing the Company’s financial and operational performance and comparing such performance to peers and competitors.

Non-GAAP Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, acquisition-related transaction costs and stock-based compensation. It is presented as a supplemental measure of the Company’s performance. However, Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of the Company’s results as reported under GAAP.

Non-GAAP Adjusted Net Income is defined as net income before stock-based compensation, acquisition-related transaction costs and amortization of purchased intangibles and any tax impact related to these items.

Non-GAAP Adjusted Net Income Per Diluted Share is defined as Non-GAAP Adjusted Net Income divided by the weighted average diluted shares outstanding. Management considers all of these non-GAAP financial measures to be useful indicators of the Company’s performance and a measure of historical trends.

The following items are excluded from non-GAAP Adjusted Net Income and related Per Diluted Share financial measures referenced above, and the reasons therefore are:

  • Stock-based compensation — Excluded because these are non-cash expenses that management does not consider useful in assessing ongoing operating results or performance of the business, and also because the amount of the expense is not totally within the Company’s control since it is based on factors such as stock price, volatility and interest rates which may be unrelated to the Company’s performance during the period the expense is incurred.
  • Amortization of purchased intangibles — Purchased intangibles are amortized over their estimated useful life and generally cannot be influenced after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Thus, including such charges does not accurately reflect the performance for the period in which such charge is incurred.
  • Acquisition-related transaction costs — Transaction costs associated with acquisitions are non-recurring and related specifically to a subject acquisition. Accordingly, management does not believe that they reflect the underlying performance of ongoing business operations for the period incurred.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform and how we integrate our thinking to solve complicated problems. In his session at 19th Cloud Expo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and sh...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Onalytica. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
IoT is rapidly changing the way enterprises are using data to improve business decision-making. In order to derive business value, organizations must unlock insights from the data gathered and then act on these. In their session at @ThingsExpo, Eric Hoffman, Vice President at EastBanc Technologies, and Peter Shashkin, Head of Development Department at EastBanc Technologies, discussed how one organization leveraged IoT, cloud technology and data analysis to improve customer experiences and effici...
As data explodes in quantity, importance and from new sources, the need for managing and protecting data residing across physical, virtual, and cloud environments grow with it. Managing data includes protecting it, indexing and classifying it for true, long-term management, compliance and E-Discovery. Commvault can ensure this with a single pane of glass solution – whether in a private cloud, a Service Provider delivered public cloud or a hybrid cloud environment – across the heterogeneous enter...
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
Successful digital transformation requires new organizational competencies and capabilities. Research tells us that the biggest impediment to successful transformation is human; consequently, the biggest enabler is a properly skilled and empowered workforce. In the digital age, new individual and collective competencies are required. In his session at 19th Cloud Expo, Bob Newhouse, CEO and founder of Agilitiv, drew together recent research and lessons learned from emerging and established compa...
Whether your IoT service is connecting cars, homes, appliances, wearable, cameras or other devices, one question hangs in the balance – how do you actually make money from this service? The ability to turn your IoT service into profit requires the ability to create a monetization strategy that is flexible, scalable and working for you in real-time. It must be a transparent, smoothly implemented strategy that all stakeholders – from customers to the board – will be able to understand and comprehe...
"IoT is going to be a huge industry with a lot of value for end users, for industries, for consumers, for manufacturers. How can we use cloud to effectively manage IoT applications," stated Ian Khan, Innovation & Marketing Manager at Solgeniakhela, in this SYS-CON.tv interview at @ThingsExpo, held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA.
Extracting business value from Internet of Things (IoT) data doesn’t happen overnight. There are several requirements that must be satisfied, including IoT device enablement, data analysis, real-time detection of complex events and automated orchestration of actions. Unfortunately, too many companies fall short in achieving their business goals by implementing incomplete solutions or not focusing on tangible use cases. In his general session at @ThingsExpo, Dave McCarthy, Director of Products...
Information technology is an industry that has always experienced change, and the dramatic change sweeping across the industry today could not be truthfully described as the first time we've seen such widespread change impacting customer investments. However, the rate of the change, and the potential outcomes from today's digital transformation has the distinct potential to separate the industry into two camps: Organizations that see the change coming, embrace it, and successful leverage it; and...
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, discussed why and how ReadyTalk diverted from healthy revenue and mor...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Major trends and emerging technologies – from virtual reality and IoT, to Big Data and algorithms – are helping organizations innovate in the digital era. However, to create real business value, IT must think beyond the ‘what’ of digital transformation to the ‘how’ to harness emerging trends, innovation and disruption. Architecture is the key that underpins and ties all these efforts together. In the digital age, it’s important to invest in architecture, extend the enterprise footprint to the cl...
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, discussed the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They also reviewed two "free infrastructure" pr...
Businesses and business units of all sizes can benefit from cloud computing, but many don't want the cost, performance and security concerns of public cloud nor the complexity of building their own private clouds. Today, some cloud vendors are using artificial intelligence (AI) to simplify cloud deployment and management. In his session at 20th Cloud Expo, Ajay Gulati, Co-founder and CEO of ZeroStack, will discuss how AI can simplify cloud operations. He will cover the following topics: why clou...
"Dice has been around for the last 20 years. We have been helping tech professionals find new jobs and career opportunities," explained Manish Dixit, VP of Product and Engineering at Dice, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.